Conceptmap (aml)

Rest and Activity Diagnostic Tests: 1. Adequate rest periods • Bone marrow examination 2. PT w/ walker 3. Exercises for strengthening (Provides information 4. ROM cells within 5. Callabout for assistance to getthe up

marrow, the type of erythropoieses, and the maturity of

1. 2. 3. 4.

Identify platelet counts. Monitor VS Q4h and as needed. Avoid use of rectal thermometer/digital exam. Test all secretions and excretions.

Goal # 1:

Labs: CBC w/diff



Labs / Diagnosti cs

Platelets. Electrolytes Serum iron Total protein Albumin Prealbumin

Ineffective protection R/T reduced platelet count and risk for

Foods with low potential to cause nausea and vomiting (dry toast, crackers, ginger ale, cola, popsicles, gelatin, baked or boiled potatoes, and fresh or canned fruit.) Serve meat in the morning. Small frequent nutritious meals.

Medication s:

Consistent weighing is important to ensure accuracy in

2. 3. 4.

5.

Inspect buccal region/throat for swelling and lesions daily. Culture any oral lesions. Assist with mouth care and oral rinses. Encourage soft bristle toothbrush. Administer meds as ordered to

Goal #2:

Pt is free from oral inflammatio n, oral bleeding, and

NSG Dx 2: NSG Dx 1:

Dietary Considerati ons:

1.

Pt will be free of signs and symptoms of bleeding.

Diet / Supplements:

Arsenic trioxide (Trisenox) and all-trans retinoic acid (ATRA) are anti-cancer drugs that can be used alone or in combination with chemotherapy for remission induction of a certain subtype of AML called promyelocytic leukemia. These drugs

Interventions:

Interventions:

Client’s Data:

Acute

Impaired oral mucous membranes secondary to anemia and reduced platelets.

NSG Dx 3: Fatigue related to anemia.

Goal # 3:

Pt states return of near-normal activity levels, and achieves tolerance of Interventions: 1.

2.

Myelocytic

3.

4.

Leukemia Medical Treatmen t for Disease

Risk Factors of



Increasing age



Sex (M or F)

Chemotherapy & Radiation



Previous cancer treatment

Single agent or combo chemo is the treatment of choice for most types of leukemia, with the goal of eradicating leukemic cells



Exposure to

Common Treatments for Disease Process:

NSG Dx 4: Risk for infection R/T altered WBC

1. 2.

3.

Dangerous chemical exposure

Goal # 4:

Pt has reduced risk of infection as

Interventions:

radiation 

5.

Assess specific cause of fatigue. Monitor Hgb, Hct, and RBC levels. Assess current activity level. Stress importance of rest periods. Instruct

4.

Monitor WBC w/differential. Assess for local or systemic signs of infection such as fever, chills, malaise, swelling, and pain. If pt is hospitalized put in private room and have pt on reverse isolation. Instruct pt to avoid contact with persons have a cold or infections.